首页> 外文期刊>Journal of drug targeting >Regenerative inductive therapy based on DDS technology of protein and gene.
【24h】

Regenerative inductive therapy based on DDS technology of protein and gene.

机译:基于蛋白质和基因的DDS技术的再生诱导疗法。

获取原文
获取原文并翻译 | 示例
           

摘要

Recent development of biomedical engineering including biomaterials and drug delivery system (DDS) as well as basic biology and medicine has enabled cells to induce regeneration repairing of defective tissues as well as substitute the biological functions of damaged organs. For successful tissue regeneration, it is undoubtedly indispensable to give cells a local environment which allows cells to efficiently promote their proliferation and differentiation and consequently induce cell-based tissue regeneration. Tissue engineering is one of the biomedical forms to create this regeneration environment of cells. The tissue and organ repairing based on their regeneration induction has been realized by combining cells with the tissue engineering technology or methodology in a surgical or internally medical manner. This paper overviews the present status and future direction of tissue engineering for regenerative inductive therapy, briefly explaining the key technology of tissue engineering, especially DDS of growth factor and gene.
机译:包括生物材料和药物输送系统(DDS)以及基础生物学和医学在内的生物医学工程的最新发展使细胞能够诱导缺陷组织的再生修复,并替代受损器官的生物学功能。对于成功的组织再生,毫无疑问,必须为细胞赋予局部环境,使细胞能够有效地促进其增殖和分化,从而诱导基于细胞的组织再生。组织工程是创造这种细胞再生环境的生物医学形式之一。通过将细胞与组织工程技术或方法以外科或内部医学方式结合在一起,已经实现了基于其再生诱导的组织和器官修复。本文概述了再生诱导治疗组织工程的现状和未来方向,简要介绍了组织工程的关键技术,特别是生长因子和基因的DDS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号